MedTech leader that needs a take on brand, but is short on time?
Introducing Second Opinion Sprints. :60 POVs on brand, marketing, and commercial strategy for growth-stage MedTech leaders who are building fast and can’t afford to ignore any of it.
New episodes drop weekly on YouTube. Watch the first one below.
An Act of Compassionate Innovation. One of the greatest limitations for patients living with lymphedema is the visual, mental,...
Second Opinion. Now on YouTube. The requests kept coming. More Second Opinion. More sharp takes on brand strategy for MedTech...
A New Answer to Back Pain. A $1B Exit. Lower back pain. One of the most common and most misunderstood...
Build to the stage. Scale the story. Win big. Part VI in our “When to Invest In Brand” for growth-stage...
The Practical Reality: Brand Investment Is About Intelligent Sequencing. Part V in our “When to Invest In Brand” for growth-stage...
Why MedTech Companies Can’t Wait Past Series B To Build A Strategic Brand. Part IV in our “When to Invest...
The Series A–B Inflection: When Brand Becomes MedTech Infrastructure Part II in our “When to Invest In Brand” for growth-stage...
Picking a Fight with Calcium. Scoring a $1B TKO. Cardiovascular Systems, Inc. had a bold product, an aggressive culture,...
Part 2: Why Brand Strategy Needs to Start Earlier Than Most Founders Think (Late Seed to Early A) In early-stage...
When to Invest in Brand (And Why Timing Is Everything in MedTech) Part I: The quiet question shaping MedTech...